DeepMed Research

NATIONAL INSTITUTES OF HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary, Private

Established: 1948-01-01

Employees: 1K

Market Cap: -

Website: http://www.nidcr.nih.gov

Clinical Trials

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

Recruiting

Conditions: Urothelial Cancer
Genitourinary Cancer
Urogenital Neoplasms
Bladder Cancer
Urogenital Cancer

First Posted Date: 2021-06-11

Last Posted Date: 2025-05-22

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 1000

Registration Number: NCT04923178

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV

Phase 1

Recruiting

Conditions: EBV/KSHV-associated Lymphomas
Viral Associated Malignancies
Kaposi Sarcoma

Interventions: Drug: Pomalidomide
Drug: Nivolumab

First Posted Date: 2021-05-26

Last Posted Date: 2025-04-27

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 58

Registration Number: NCT04902443

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

The Impact of the COVID-19 Pandemic on Eating Behavior and Weight Change

Completed

Conditions: Obesity
COVID-19

First Posted Date: 2021-05-21

Last Posted Date: 2025-04-08

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 5056

Registration Number: NCT04896060

Locations: 🇺🇸
NIDDK, Phoenix, Phoenix, Arizona, United States

Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)

Phase 2

Completed

Conditions: Adenosquamous Carcinoma of the Pancreas

Interventions: Drug: Minnelide

First Posted Date: 2021-05-21

Last Posted Date: 2025-04-02

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 15

Registration Number: NCT04896073

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors

Phase 1

Recruiting

Conditions: Rhabdomyosarcoma
Sarcoma, Ewing

Interventions: Drug: PEN-866
Drug: Vincristine
Drug: Temozolomide

First Posted Date: 2021-05-18

Last Posted Date: 2025-04-15

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 64

Registration Number: NCT04890093

Locations: 🇺🇸
Childrens National Medical Center, Washington, District of Columbia, United States
🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies

Recruiting

Conditions: RASopathy
Cardiofaciocutaneous Syndrome
Legius Syndrome
Noonan Syndrome
Costello Syndrome
Capillary Arteriovenous Malformation Syndrome

First Posted Date: 2021-05-17

Last Posted Date: 2025-05-06

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 500

Registration Number: NCT04888936

Locations: 🇺🇸
National Cancer Institute - Shady Grove, Rockville, Maryland, United States
🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Systematically Assessing Changes in Plexiform Neurofibroma Related Disfigurement From Photographs of Subjects With Neurofibromatosis Type 1 on a Phase 2 Clinical Trial

Completed

Conditions: Neurofibromatosis 1

First Posted Date: 2021-05-10

Last Posted Date: 2024-03-22

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 52

Registration Number: NCT04879160

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN)

Not Applicable

Recruiting

Conditions: Melanoma

Interventions: Behavioral: Control
Behavioral: Intervention Arm

First Posted Date: 2021-04-30

Last Posted Date: 2025-05-23

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 80

Registration Number: NCT04866810

Locations: 🇺🇸
Loma Linda University, Loma Linda, California, United States
🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

TReatment for ImmUne Mediated PathopHysiology

Phase 2

Recruiting

Conditions: Fulminant Hepatic Failure
Immune Dysregulation
Hepatic Encephalopathy
Acute Liver Injury
Acute Liver Failure

Interventions: Drug: High-dose methylprednisolone
Drug: Equine anti-thymocyte globulin
Drug: Placebo for prednisolone
Drug: Prednisolone
Drug: Placebo for infusions
Drug: Diphenhydramine
Drug: Methylprednisolone

First Posted Date: 2021-04-27

Last Posted Date: 2025-04-04

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 163

Registration Number: NCT04862221

Locations: 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸
Lucile Packard Children's Hospital, Palo Alto, California, United States
🇺🇸
University of California San Francisco Benioff Children's Hospital, San Francisco, California, United States

and more 19 locations

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Phase 2

Recruiting

Conditions: Resectable Pancreatic Adenocarcinoma
Pancreatic Acinar Cell Carcinoma
Resectable Pancreatic Carcinoma
Pancreatic Adenosquamous Carcinoma
Pancreatic Squamous Cell Carcinoma
Resectable Pancreatic Acinar Cell Carcinoma
Resectable Pancreatic Adenosquamous Carcinoma

Interventions: Procedure: Biospecimen Collection
Procedure: Computed Tomography
Procedure: Magnetic Resonance Imaging
Drug: Olaparib
Drug: Placebo Administration

First Posted Date: 2021-04-26

Last Posted Date: 2025-05-23

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 152

Registration Number: NCT04858334

Locations: 🇺🇸
PCR Oncology, Arroyo Grande, California, United States
🇺🇸
Mercy Hospital Washington, Washington, Missouri, United States
🇺🇸
Saint Patrick Hospital - Community Hospital, Missoula, Montana, United States

and more 439 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy